Aptevo Therapeutics

APVO

Börsenwert 2,91 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Sessa Capital New York	3,98 Mio. $	–	–	–
2	2 Dimensional Fund Advisors Austin, Texas	2,19 Mio. $	–	–	–
3	3 Fidelity Investments Boston, Massachusetts	1,53 Mio. $	–	–	–
4	4 Vanguard Group Malvern, Pennsylvania	1,45 Mio. $	–	–	–
5	5 Precept Management Dallas, Texas	1,21 Mio. $	–	–	–
6	6 BlackRock New York	946.000 $	–	–	–
7	7 Millennium Management New York	931.000 $	–	–	–
8	8 Legal & General Group London, United Kingdom	815.000 $	–	–	–
9	CL 9 CSS LLC Chicago, Illinois	733.000 $	–	–	–
10	10 D.E. Shaw & Co New York	654.000 $	–	–	–
11	FM 11 Fondren Management Houston, Texas	292.000 $	–	–	–
12	12 AQR Arbitrage Greenwich, Connecticut	274.000 $	–	–	–
13	13 Morgan Stanley New York	248.000 $	–	–	–
14	14 Geode Capital Management Boston, Massachusetts	199.000 $	–	–	–
15	15 Goldman Sachs New York	192.000 $	–	–	–
16	16 Element Capital Management New York	158.000 $	–	–	–
17	17 Spark Investment Management New York	127.000 $	–	–	–
18	18 Paloma Partners Greenwich, Connecticut	121.000 $	–	–	–
19	19 Northern Trust Chicago, Illinois	109.000 $	–	–	–
20	20 Bridgeway Capital Management Houston, Texas	95.000 $	–	–	–
21	21 LMR Partners London, United Kingdom	95.000 $	–	–	–
22	22 Parametric Portfolio Associates Seattle, Washington	90.000 $	–	–	–
23	23 Invesco Atlanta, Georgia	84.000 $	–	–	–
24	24 Oxford Asset Management Oxford, United Kingdom	80.000 $	–	–	–
25	ARTA 25 A.R.T. Advisors New York	72.000 $	–	–	–

Aptevo Therapeutics APVO Börsenwert 2,91 Mio. $

Aptevo Therapeutics

APVO

Börsenwert 2,91 Mio. $